Sweden
· Delayed Price · Currency is SEK Dextech Medical AB Statistics
Total Valuation
Dextech Medical AB has a market cap or net worth of SEK 76.53 million. The enterprise value is 58.54 million.
| Market Cap | 76.53M |
| Enterprise Value | 58.54M |
Important Dates
The next estimated earnings date is Thursday, February 27, 2025.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Dextech Medical AB has 18.49 million shares outstanding. The number of shares has increased by 2.51% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 18.49M |
| Shares Change (YoY) | +2.51% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 54.75% |
| Owned by Institutions (%) | n/a |
| Float | 7.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.02 |
| PB Ratio | 2.69 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.88 |
| EV / Sales | 13.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 27.05
| Current Ratio | 27.05 |
| Quick Ratio | 27.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -15.93% and return on invested capital (ROIC) is -11.63%.
| Return on Equity (ROE) | -15.93% |
| Return on Assets (ROA) | -11.37% |
| Return on Capital (ROIC) | -11.63% |
| Revenue Per Employee | 4.32M |
| Profits Per Employee | -4.93M |
| Employee Count | 1 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.09% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +8.09% |
| 50-Day Moving Average | 4.29 |
| 200-Day Moving Average | 4.75 |
| Relative Strength Index (RSI) | 47.28 |
| Average Volume (20 Days) | 5,504 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dextech Medical AB had revenue of SEK 4.32 million and -4.93 million in losses. Loss per share was -0.26.
| Revenue | 4.32M |
| Gross Profit | 4.32M |
| Operating Income | -5.76M |
| Pretax Income | -4.93M |
| Net Income | -4.93M |
| EBITDA | -5.40M |
| EBIT | -5.76M |
| Loss Per Share | -0.26 |
Balance Sheet
| Cash & Cash Equivalents | 17.99M |
| Total Debt | n/a |
| Net Cash | 17.99M |
| Net Cash Per Share | 0.97 |
| Equity (Book Value) | 28.47M |
| Book Value Per Share | 1.54 |
| Working Capital | 17.90M |
Cash Flow
| Operating Cash Flow | -1.31M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -133.11% and -113.95%.
| Gross Margin | 100.00% |
| Operating Margin | -133.11% |
| Pretax Margin | -113.95% |
| Profit Margin | -113.95% |
| EBITDA Margin | -124.91% |
| EBIT Margin | -133.11% |
| FCF Margin | n/a |
Dividends & Yields
Dextech Medical AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.51% |
| Shareholder Yield | -2.51% |
| Earnings Yield | -6.32% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |